Electrochemical Assessment of CYP3A4 Catalytic Activity in Bactosomes

被引:0
|
作者
Koroleva, Polina I. [1 ,2 ]
Kuzikov, Alexey V. [1 ,2 ]
Gilep, Andrei A. [1 ]
Bulko, Tatiana V. [1 ]
Shumyantseva, Victoria V. [1 ,2 ]
机构
[1] Inst Biomed Chem, Pogodinskaya St 10, Moscow 119121, Russia
[2] Pirogov Russian Natl Res Med Univ, Moscow, Russia
基金
俄罗斯科学基金会;
关键词
Electrochemical analysis; Screen-printed electrodes; Voltammetry; Bioreactor; Electron transfer; Enzymatic assay; LIVER MICROSOMAL BIOREACTOR; DRIVEN DRUG-METABOLISM; CYTOCHROME-P450; 3A4; DICLOFENAC; FILM; BIOCATALYSIS; ACTIVATION; EFFICIENCY; REDUCTASE; KINETICS;
D O I
10.1007/s12668-024-01539-1
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
In this work, we present investigation on the behavior of bactosomes containing human cytochrome CYP3A4 in comparison with recombinant enzyme. The bactosomes were adsorbed on the surface of screen-printed electrodes modified with didodecyldimethylammonium bromide. We have shown that bactosomes are effective bioreactors in the case of drug metabolic electroenzymatic reactions. The electrocatalytic reaction was conducted at a working potential of - 0.50 divided by - 0.55 V. Drug conversion was registered by means of measuring of formaldehyde as product of N-demethylation reaction of erythromycin and time-dependent electrochemical oxidation of diclofenac during electrolysis at controlled working potential. The efficiencies of electrocatalysis of erythromycin N-demethylation as well-known cytochrome P450 3A4 substrate in the case of bactosomes containing human cytochrome P450 3A4 was 3.5 +/- 0.4 times higher in comparison with highly purified cytochrome P450 3A4-electrode as catalyst. The efficiencies of electrocatalysis of diclofenac 5-hydroxylation in the case of bactosomes were 3.1 +/- 0.3 times higher than for purified enzyme. Bactosomes are effective electrochemical enzymatic nanobioreactors with a high electroenzymatic efficiency for metabolite production.
引用
收藏
页码:2930 / 2939
页数:10
相关论文
共 50 条
  • [1] Role of CYP3A4 in kinase inhibitor metabolism and assessment of CYP3A4 activity
    Mikus, Gerd
    Foerster, Kathrin Isabelle
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S1592 - S1599
  • [2] Resveratrol modulates the catalytic activity of human CYP3A4 and CYP3A5.
    Chang, TKH
    Yeung, KYR
    FASEB JOURNAL, 2000, 14 (08): : A1336 - A1336
  • [3] CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity
    García-Martín, E
    Martínez, C
    Pizarro, RM
    García-Gamito, FJ
    Gullsten, H
    Raunio, H
    Agúndez, JAG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (03) : 196 - 204
  • [4] CYP3A4*16 and CYP3A4*18 Alleles Found in East Asians Exhibit Differential Catalytic Activities for Seven CYP3A4 Substrate Drugs
    Maekawa, Keiko
    Harakawa, Noriko
    Yoshimura, Takuya
    Kim, Su-Ryang
    Fujimura, Yoshiyuki
    Aohara, Fumika
    Sai, Kimie
    Katori, Noriko
    Tohkin, Masahiro
    Naito, Mikihiko
    Hasegawa, Ryuichi
    Okuda, Haruhiro
    Sawada, Jun-Ichi
    Niwa, Takuro
    Saito, Yoshiro
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (12) : 2100 - 2104
  • [5] Pioglitazone: Effect on CYP3A4 activity
    Nowak, SN
    Edwards, DJ
    Clarke, A
    Anderson, GD
    Jaber, LA
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (12): : 1299 - 1302
  • [6] Simultaneous assessment of CYP3A4 and CYP1A2 activity in vivo with alprazolam and caffeine
    Schmider, J
    Brockmöller, J
    Arold, G
    Bauer, S
    Roots, I
    PHARMACOGENETICS, 1999, 9 (06): : 725 - 734
  • [7] Expression of CYP3A4 mRNA is correlated with CYP3A4 protein level and metabolic activity in human liver
    Watanabe, M
    Kumai, T
    Matsumoto, N
    Tanaka, M
    Suzuki, S
    Satoh, T
    Kobayashi, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 (04) : 459 - 462
  • [8] Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity
    Westlind-Johnsson, A
    Hermann, R
    Huennemeyer, A
    Hauns, B
    Lahu, G
    Nassr, N
    Zech, K
    Ingelman-Sundberg, M
    von Richter, O
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (04) : 339 - 349
  • [9] Effect of influenza immunization on CYP3A4 activity
    Hayney, MS
    Hammes, RJ
    Fine, JP
    Bianco, JA
    VACCINE, 2001, 20 (5-6) : 858 - 861
  • [10] Effect of NIPRISANA® on CYP3A4 activity in vitro
    Adzu, Bulus
    Masimirembwa, Collen
    Mustapha, Kudirat Bola
    Thelingwani, Roslyn
    Kirim, Rukaiyatu Abdullahi
    Gamaniel, Karniyus Shingu
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2015, 40 (01) : 115 - 118